Cite
HARVARD Citation
Allin, D. et al. (2018). Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. European journal of cancer. pp. 165-175. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Allin, D. et al. (2018). Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. European journal of cancer. pp. 165-175. [Online].